Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region

被引:0
|
作者
Maula, SM
Luukkaa, M
Grénman, R
Jackson, D
Jalkanen, S
Ristamäki, R
机构
[1] Turku Univ, MediCity Res Labs, FIN-20520 Turku, Finland
[2] Turku Univ, Sch Biomed Sci, Natl Publ Hlth Inst, Dept Med Microbiol, FIN-20520 Turku, Finland
[3] Turku Univ, Cent Hosp, Dept Radiotherapy & Oncol, FIN-20520 Turku, Finland
[4] Turku Univ, Cent Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland
[5] John Radcliffe Hosp, Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DS, England
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Head and neck squamous cell carcinomas (HNSCCs) frequently disseminate to regional lymph nodes. To investigate the possible mechanisms involved, we studied the expression of cancer cell adhesion molecules together with lymphatic vascular and blood vascular markers in a panel of 97 primary HNSCC tumors and correlated expression levels with conventional clinicopathological parameters and with long-term prognosis. In particular, we measured the density of intratumoral and peritumoral lymph vessels as assessed with the marker lymphatic vessel endothelial hyaluronan receptor 1 (LYVE-1) and the density of tumor CD44, a receptor up-regulated in many metastatic cancers. Intratumoral LYVE-1(+) lymphatic vessels were clearly associated with a higher risk for local relapse as well as with poor disease-specific prognosis (P = 0.02 and 0.0009, respectively). In contrast, a high density of peritumoral LYVE-1(+) vessels was a sign of favorable survival (P = 0.05). Strong primary tumor CD44 expression was associated with a poor prognosis, an increased risk of local recurrence (P = 0.03 and 0.02, respectively), and an increase in resistance to radiation therapy (P = 0.03). CD44 was the only factor with an independent prognostic value for the disease-specific overall survival (P = 0.04). Our results suggest that intratumoral lymphatics play a greater role than peritumoral lymphatics in nodal metastasis of HNSCC and that tumor CD44 levels can predict sensitivity to radiation therapy. These parameters may be useful predictive and prognostic tools in the clinical management of HNSCC.
引用
收藏
页码:1920 / 1926
页数:7
相关论文
共 50 条
  • [21] PROGNOSTIC IMPLICATIONS OF PERINEURAL SPREAD IN SQUAMOUS CARCINOMAS OF THE HEAD AND NECK
    SOO, KC
    CARTER, RL
    OBRIEN, CJ
    BARR, L
    BLISS, JM
    SHAW, HJ
    LARYNGOSCOPE, 1986, 96 (10): : 1145 - 1148
  • [22] Frequent chromosome Y loss in primary, second primary and metastatic squamous cell carcinomas of the head and neck region
    Kujawski, M
    Jarmuz, M
    Rydzanicz, M
    Szukala, K
    Wierzbicka, M
    Grenman, R
    Golusinski, W
    Szyfter, K
    CANCER LETTERS, 2004, 208 (01) : 95 - 101
  • [23] Cetuximab in squamous cell head and neck carcinomas
    Gebbia, V.
    Giuliani, F.
    Valori, V. M.
    Agueli, R.
    Coiucci, G.
    Maiello, E.
    ANNALS OF ONCOLOGY, 2007, 18 : 5 - 7
  • [24] Basaloid squamous cell carcinomas of the head and neck
    Thariat, J.
    Badoual, C.
    Faure, C.
    de Mones, E.
    Butori, C.
    Santini, J.
    Poissonnet, G.
    Maingon, P.
    Faivre, S.
    Klijanienko, J.
    Saint-Guily, J. Lacau
    Righini, C. A.
    BULLETIN DU CANCER, 2009, 96 (10) : 989 - 1004
  • [25] Risk of multiple squamous cell carcinomas both in the esophagus and the head and neck region
    Muto, M
    Takahashi, M
    Ohtsu, A
    Ebihara, S
    Yoshida, S
    Esumi, H
    CARCINOGENESIS, 2005, 26 (05) : 1008 - 1012
  • [26] TREATMENT OF SQUAMOUS-CELL CARCINOMAS OF HEAD AND NECK REGION WITH COBALT AND BLEOMYCIN
    KAPSTAD, B
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1978, 4 (1-2): : 91 - 94
  • [27] CHEMOSENSITIVITY TESTING OF XENOGRAFTED SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK REGION
    ELPRANA, D
    KUIJPERS, W
    WESSELS, JMC
    WAGENER, DJT
    VANDENBROEK, P
    ANTICANCER RESEARCH, 1992, 12 (6B) : 2229 - 2240
  • [28] Immunological approaches to the treatment of squamous cell carcinomas of the head and neck region (HNSCC)
    Wollenberg, B
    LARYNGO-RHINO-OTOLOGIE, 1998, 77 (11) : 631 - 634
  • [29] ELECTIVE IRRADIATION OF NECK LYMPHATICS FOR SQUAMOUS CELL CARCINOMAS OF NASOPHARYNX AND OROPHARYNX
    BERGER, DS
    FLETCHER, GH
    LINDBERG, RD
    JESSE, RH
    AMERICAN JOURNAL OF ROENTGENOLOGY RADIUM THERAPY AND NUCLEAR MEDICINE, 1971, 111 (01): : 66 - &
  • [30] RECURRENT CYTOGENETIC ABNORMALITIES IN SQUAMOUS-CELL CARCINOMAS OF THE HEAD AND NECK REGION
    VANDYKE, DL
    WORSHAM, MJ
    BENNINGER, MS
    KRAUSE, CJ
    BAKER, SR
    WOLF, GT
    DRUMHELLER, T
    TILLEY, BC
    CAREY, TE
    GENES CHROMOSOMES & CANCER, 1994, 9 (03): : 192 - 206